Venous thromboembolism in pregnancy

Current Treatment Options in Cardiovascular Medicine

Volumn 11, Issue 2, 2009, Pages 104-113

  Villa Forte Gomes, Marcelo P ^a  

^a Section of Vascular Medicine Department of Cardiovascular Medicine Heart and Vascular Institute ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; DALTEPARIN; DANAPAROID; ENOXAPARIN; FIBRINOLYTIC AGENT; FONDAPARINUX; HEPARIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; ORAL CONTRACEPTIVE AGENT; TINZAPARIN; WARFARIN;

BLEEDING; CESAREAN SECTION; CLINICAL TRIAL; COMPRESSION THERAPY; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MILK LEVEL; DRUG SAFETY; FRAGILITY FRACTURE; HEPARIN INDUCED THROMBOCYTOPENIA; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERCOAGULABILITY; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MATERNAL MORTALITY; NONHUMAN; PLACENTAL TRANSFER; PREGNANCY OUTCOME; PREGNANT WOMAN; PREVALENCE; PROTHROMBIN TIME; PUERPERIUM; RECOMMENDED DRUG DOSE; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; THROMBECTOMY; THROMBOPHILIA; THROMBOSIS PREVENTION; TREATMENT DURATION; TREATMENT INDICATION; VAGINAL DELIVERY; VENOUS THROMBOEMBOLISM;

EID: 62649124241     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-009-0011-y     Document Type: Review

References (74)

1. Villasanta U: Thromboembolic disease in pregnancy. Am J Obstet Gynecol 1965, 93:142-160.
2. Macklon NS, Greer IA: Venous thromboembolic disease in obstetrics and gynaecology: The Scottish experience. Scott Med J 1996, 41:83-86.
3. James AH, Jamison MG, Brancazio LR, et al.: Venous thromboembolism during pregnancy and the postpartum period: Incidence, risk factors, and mortality. Am J Obstet Gynecol 2006, 194:1311-1315.
4. McColl M, Ramsay JE, Tait RC, et al.: Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 1997, 8:1183-1188.
5. Sharma S, Monga D: Venous thromboembolism during pregnancy and the postpartum period: Incidence and risk factors in a large Victorian health service. Aust N Z J Obstet Gynaecol 2008, 48:44-49.
6. Jacobsen AF, Skjeldestad FE, Sandset PM: Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium: A register-based case-control study. Am J Obstet Gynecol 2008, 198:233-237.
7. Ginsberg JS, Brill-Edwards P, Burrows RF, et al.: Venous thrombosis during pregnancy: Leg and trimester of presentation. Thromb Haemost 1992, 67:519-520.
8. Simpson EL, Lawrenson RA, Nightingale AL, et al.: Venous thromboembolism in pregnancy and the puerperium: Incidence and additional risk factors from a London perinatal database. Br J Obstet Gynaecol 2001, 108:56-60.
9. Chang J, Elam-Evans LD, Berg CJ, et al.: Pregnancy-related mortality surveillance: United States, 1991-1999. MMWR Surveill Summ 2003, 52:1-8.
10. Robertson L, Wu O, LanAhorne P, et al.: Thrombophilia in pregnancy: a systematic review. Br J Haematol 2005, 132:171-196.
11. Marik PE, Plante LA: Venous thromboembolism during pregnancy. N Engl J Med 2008, 359:2025-2033.
12. Greer IA, Thomson AJ, on behalf of the Guidelines and Audit Committee of the Royal College of Obstetricians and Gynaecologists: Thromboembolic disease in pregnancy and the puerperium: Acute management. Green-top Guideline No. 28. London, February 2007. Available at http://www.rcog.org.uk/resources/Public/pdf/ green_top_28_thromboembolic_minorrevision.pdf. Accessed November 13, 2008.
13. James AH, Tapson VF, Goldhaber SZ: Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol 2005, 193:216-219.
14. Deneaux-Tharaux C, Carmona E, Bowvier-Colle M-H, et al.: Postpartum maternal mortality and cesarean delivery. Obstet Gynecol 2006, 108:541-548.
15. Bates SM, Greer IA, Pabinger I, et al.: Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy. American College of Chest Guidelines Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133(6 Suppl): 844S-886S.
16. Bremme KA: Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003, 16: 153-168.
17. Rosenthal T, Shani M, Deutsch V, et al.: The Budd-Chiari syndrome after pregnancy. Report of two cases and a review of the literature. Am J Obstet Gynecol 1972, 113: 789-792.
18. Deitcher SR, Gomes MPV: Hypercoagulable state testing and malignancy screening following venous thromboembolic events. Vasc Med 2003, 8:33-46.
19. Heit JA, Kobbervig CE, James AH, et al.: Trends in the incidence of venous thromboembolism during pregnancy or postpartum: A 30-year population-based study. Ann Intern Med 2005, 143:697-706.
20. Gerhardt A, Scharf RE, Beckman MW, et al.: Prothrombin and factor V mutations in women with thrombosis during pregnancy and the puerperium. N Engl J Med 2000, 342:374-380.
21. Ray JG, Chan WS: Deep vein thrombosis during pregnancy and the puerperium: A meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv 1999, 54:265-271.
22. Blanco-Molina A, Trujillo-Santos J, Criado J, et al.: Venous thromboembolism during pregnancy or postpartum: Findings from the RIETE Registry. Thromb Haemost 2007, 97:186-190.
23. Martinelli I, De Stefano V, Taioli E, et al.: Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Thromb Haemost 2002, 87:791-795.
24. Pallasmaa N, Ekblad U, Gissler M: Severe maternal morbidity and the mode of delivery. Acta Obstet Gynecol Scand 2008, 87:662-668.
25. Rodger MA, Avruch LI, Howley HE, et al.: Pelvic magnetic resonance venography reveals high rate of pelvic vein thrombosis after cesarean section. Am J Obstet Gynecol 2006, 194:436-437.
26. Holmgren C, Aagaard-Tillery KM, Silver RM, et al.: Hyperemesis in pregnancy; an evaluation of treatment strategies with maternal and neonatal outcomes. Am J Obstet Gynecol 2008, 198:56.e1-56.e4.
27. Mancuso A, De Vivo A, Fanara G, et al.: Upper body venous thrombosis associated with ovarian stimulation: Case report and review of the literature. Clin Exp Obstet Gynecol 2005, 32:149-154.
28. Chan WS, Dixon ME: The "ART" of thromboembolism: a review of assisted reproductive technology and thromboembolic complications. Thromb Res 2008, 121:713-726.
29. Brenner B: Haemostatic changes in pregnancy. Thromb Res 2004, 114:409-414.
30. Macklon NS, Greer IA: The deep venouA system in the puerperium: an ultrasound study. Br J Obstet Gynaecol 1997, 104:198-200.
31. Biron-Andreani C, Schved J-F, Daures J-P: Factor V Leiden mutation and pregnancy-related venous thromboembolism: What is the exact risk? Results from a meta-analysis. Thromb Haemost 2006, 96:14-18.
32. Bank I, Libourel EJ, Middeldorp S, et al.: Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. Arch Intern Med 2004, 164:1932-1937.
33. Middeldorp S, Libourel EJ, Hamulyák K, et al.: The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden. Br J Haematol 2001, 113:553-555.
34. Ogunyemi D, Cuellar F, Ku W et al.: Association between inherited thrombophilias, antiphospholipid antibodies, and lipoprotein A levels and venous thromboembolism in pregnancy. Am J Perinatol 2003, 20:17-24.
35. Ginsberg JS, Wells PS, Brill-Edwards P, et al.: Antiphospholipid antibodies and venous thromboembolism. Blood 1995, 86:3685-3691.
36. Erkan D, Yazici Y, Peterson MG, et al.: A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford) 2002, 41:924-929.
37. Gerhardt A, Scharf RE, Zotz RB: Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium. Thromb Haemost 2003, 90:77-85.
38. Simioni P, Sanson BJ, Prandoni P, et al.: Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost 1999, 81:198-202.
39. Dizon-Townson D, Miller C, Sibai B, et al.: The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005, 106:517-524.
40. Martinelli I, Legnami C, Bucciarelli P, et al.: Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost 2001, 86:800-803.
41. Samama MM, Rached RA, Horellou MH, et al.: Pregnancyassociated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone. Br J Haematol 2003, 123:327-334.
42. Martinelli I, Battaglioli T, De Stefano V, et al.: The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A. J Thromb Haemost 2008, 6:494-498.
43. Friedrich PW, Sanson BJ, Simioni P, et al.: Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: Implications for prophylaxis. Ann Intern Med 1996, 125:955-960.
44. Van Boven HH, Vandenbroucke JP, Briët E, et al.: Genegene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency. Blood 1999, 94:2590-2594.
45. Pabinger I, Grafenhofer H, Kyrle PA, et al.: Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood 2002, 100:1060-1062.
46. Brill-Edwards P, Ginsberg JS, Gent M, et al.: Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. N Engl J Med 2000, 343:1439-1444.
47. Pabinger I, Grafenhofer H, Kaider A, et al.: Risk of pregnancyassociated venous thromboembolism in women with a history of venous thromboembolism. J Thromb Haemost 2005, 3:949-954.
48. De Stefano V, Martinelli I, Rossi E, et al.: The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br J Haematol 2006, 135:386-391.
49. Ginsberg JS, Kowalchuk G, Hirsh J, et al.: Heparin therapy during pregnancy: Risks to the fetus and mother. Arch Intern Med 1989, 149:2233-2236.
50. Lepercq J, Conard J, Borel-Derlon A, et al.: Venous thromboembolism during pregnancy: A retrospective study of enoxaparin safety in 624 pregnancies. Br J Obstet Gynaecol 2001, 108:1134-1140.
51. Schaefer C, Hannemann D, Meister R, et al.: Vitamin K antagonists and pregnancy outcome: A multi-centre prospective study. Thromb Haemost 2006, 95: 949-957.
52. Chan WS, Anand S, Ginsberg JS: Anticoagulation of pregnant women with mechanical heart valves: A systematic review of the literature. Arch Intern Med 2000, 160:191-196.
53. Wesseling J, van Driel D, Heymans HAS, et al.: Coumarins during pregnancy: Long term effects on growth and development in school age children. Thromb Haemost 2001, 85:609-613.
54. Dempfle CE: Minor transplacental passage of fondaparinux in vivo. N Engl J Med 2004, 350:1914-1915.
55. Harenberg J. Treatment of a woman with lupus and thromboembolism and cutaneous intolerance of heparins using fondaparinux during pregnancy. Thromb Res 2007, 119:385-388.
56. Wijesiriwardana A, Lees DA, Lush C: Fondaparinux as anticoagulant in a pregnant woman with heparin allergy. Blood Coagul Fibrinolysis 2006, 17:147-149.
57. Lindhoff-Last E, Bauersachs R: Heparin-induced thrombocytopenia: alternative anticoagulation in pregnancy and lactation. Semin Thromb Hemost 2002, 28:439-445.
58. Richter C, Sitzmann J, Lang P, et al.: Excretion of lowmolecular-weight heparin in human milk. Br J Clin Pharmacol 2001, 52:708-710.
59. Dahlman TC: Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993, 70:254-257.
60. Nelson-Piercy A: Hazards of heparin: allergy, heparininduced thrombocytopenia and osteoporosis. Baillieres Clin Obstet Gynaecol 1997, 11:489-509.
61. Warkentin TE, Greinacher A, Koster A, et al.: Treatment and prevention of heparin-induced thrombocytopenia. Chest 2008, 133(6Suppl): 340S-380S.
62. Greer IA, Nelson-Piercy C: Low-molecular-weight heparins for thrombophrophylaxis and treatment of venous thromboembolism in pregnancy: A systematic review of safety and efficacy. Blood 2005, 106:401-407.
63. Quiñones JN, James DN, Stamilio DM, et al.: Thrombophrophylaxis after cesarean delivery: A decision analysis. Obstet Gynecol 2005, 106:733-740.
64. Rodger MA, Paidas M, McLintock C, et al.: Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 2008, 112(2 Pt 1):320-324.
65. Rai RS, Clifford K, Cohen H, et al.: High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995, 10:3301-3304.
66. Empson M, Lassere M, Craig J, et al.: Prevention of miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005, CD002859.
67. Noble LS, Kutteh WH, Lashey N, et al.: Antiphospholipid antibodies associated with recurrent pregnancy loss: Prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril 2005, 83:684-690.
68. Stephenson MD, Ballem PJ, Tsang P, et al.: Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: A randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. J Obstet Gynaecol Can 2004, 26:729-734.
69. Ahearn GS, Hadjiliadis D, Govert JA, Tapson VS: Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: A case-report and review of the literature. Arch Intern Med 2002, 162:1221-1227.
70. Stone SE, Morris TA: Pulmonary embolism during and after pregnancy. Crit Care Med 2005, 33(10 Suppl):S294-S300.
71. Gupta S, Ettles DF, Robinson GJ, et al.: Inferior vena cava filter use in pregnancy: Preliminary experience. Br J Obstet Gynaecol 2008, 115:785-788.
72. Kawamata K, Chiba Y, Tanaka R, et al.: Experience of temporary inferior vena cava filters inserted in the perinatal period to prevent pulmonary embolism in pregnant women with deep vein thrombosis. J Vasc Surg 2005, 41:652-656.
73. Horlocker TT, Wedel DJ, Benzon H, et al.: Regional anesthesia in the anticoagulated patient: Defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003, 28:172-197.
74. Ulander VM, Lehtola A, Kaaja R: Long-term outcome of deep venous thrombosis during pregnancy treated with unfractionated heparin or low molecular weight heparin. Thromb Res 2003, 111:239-242.